Peter R. Hoffmann to Antineoplastic Agents
This is a "connection" page, showing publications Peter R. Hoffmann has written about Antineoplastic Agents.
Connection Strength
0.493
-
Marciel MP, Rose AH, Martinez V, Horio DT, Hashimoto AS, Hoffmann FW, Bertino P, Hoffmann PR. Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme. Cancer Med. 2018 01; 7(1):175-183.
Score: 0.297
-
Subramaniam S, Donnellan L, Wignall A, Woodcock J, Coolen C, Pitson S, Taheri A, Young C, Hoffmann P, Prestidge CA, Joyce P. Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drug. J Control Release. 2025 Dec 10; 388(Pt 1):114299.
Score: 0.128
-
Weiland F, Arentz G, Klingler-Hoffmann M, McCarthy P, Lokman NA, Kaur G, Oehler MK, Hoffmann P. Novel IEF Peptide Fractionation Method Reveals a Detailed Profile of N-Terminal Acetylation in Chemotherapy-Responsive and -Resistant Ovarian Cancer Cells. J Proteome Res. 2016 11 04; 15(11):4073-4081.
Score: 0.068